Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06812143

Optimizing Strength Training in Older Adults

The objective of the current study is to determine whether lifting lighter loads close to failure improves strength training adaptations and function in older adults. The main questions it aims to answer are:

1. The effect of light loads on physical function 2. The effect of light loads on muscle mass, power, and strength

Researchers will compare a light-load, high-repetition program to a standard strength training program. Participants will perform supervised strength training twice per week for 20 weeks.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Exercise & Aging Lab, Queens College

Flushing, New York, 11367, United States

Location status: Recruiting

Location contact

Anoop T Balachandran

CONTACT

[email protected]

718-570-0639

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males and females aged 65 years and above
  • Inactive lifestyle (< 150 min per week of moderate intensity physical activity) and not regularly participating in a structured strength training program
  • Planning to reside in the area for the duration of the study

Exclusion criteria

  • Severe cardiac disease, including Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
  • Lung disease requiring either oral or injected steroids, or the use of supplemental oxygen
  • Short, portable mental status questionnaire with 3 or more errors
  • Severe arthritis (either osteoarthritis or rheumatoid arthritis)
  • Cancer requiring treatment in the past 1 year (melanomas excluded)
  • Development of chest pain or severe shortness of breath during the 6 min self-paced walk test
  • Parkinson's disease or other serious neurological disorders
  • Renal disease requiring dialysis
  • Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
  • Current consumption of more than 14 alcoholic drinks per week
  • Severe lower back or shoulder pain that may worsen with weightlifting exercises
  • Undergoing physical therapy involving the lower extremities
  • Living in nursing homes, assisted living facilities or other similar institutions
  • Currently enrolled in another randomized trial involving a pharmaceutical or lifestyle intervention
  • Weight change (intentional or not) over the last 6 months of > 5% of body weight, or plan to lose or gain weight during the study
  • Any other cardiovascular, pulmonary, orthopedic, neurologic, or other conditions that would preclude participation and successful completion of the protocol

Temporary Exclusion Criteria

A person meeting any of the following temporary exclusion criteria at the time of screening will not be enrolled but may be re-screened later.

  • Severe hypertension, e.g., SBP > 200 mm Hg, DBP > 110 mm Hg
  • Major surgery or fracture or hip/knee replacement within the last 6 months
  • Hospitalization within the last 6 months (excluding ER visits)

Treatment and study plan

strength training

Behavioral

This intervention involves strength training with lighter loads and higher repetitions.

Other names: Resistance training, Weight training

Primary outcomes

  1. 6-minute walk test

    Time frame: Baseline and week 21

    Change in the total distance walked in 6 minutes. The 6-minute walk test is an objective, well-validated, and clinically meaningful measure of physical function in older adults.

Secondary outcomes

  1. Lower body maximal muscle strength

    Time frame: Baseline and week 21.

    Change in lower body maximum muscle strength will be assessed using a one-repetition maximum (1RM) test on a leg press machine.

  2. Lower body muscle power

    Time frame: Baseline and week 21

    Lower body muscle peak power (W) will be assessed using a pneumatic leg press machine.

  3. Lean body mass (LBM)

    Time frame: Baseline and week 21

    Change in total lean body mass (kg) will be assessed using a dual-energy X-ray absorptiometry (DXA) scan

  4. Self-reported physical function

    Time frame: Baseline and week 21

    Self-reported physical function will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) physical function questionnaire. PROMIS measures are scored on the T-score metric. High scores mean more of the concept being measured.

  5. Get-up & go test

    Time frame: Baseline and week 21

    Change in the time (in seconds) taken to complete the get up and go test. The get up & go test will be used to assess lower body dynamic balance and fall risk

  6. 30-second chair stand test

    Time frame: Baseline and week 21

    Change in the number of repetitions completed during the 30-Second chair stand test. This test assesses lower body functional strength and power.

  7. Number of participants with adverse events

    Time frame: From enrollment to the end of 20-week intervention period

    Number of participants experiencing adverse events that are possibly or definitely related to the intervention,

  8. Physical activity enjoyment scale (PACES)

    Time frame: Week 21

    Participants will complete the 18-item Physical activity enjoyment scale (PACES) to assess their level of physical activity enjoyment. Scores range from 18 to 126 and higher scores indicate greater enjoyment.

  9. Exercise self-efficacy questionnaire

    Time frame: Week 21

    Participants will complete the exercise self-efficacy scale to assess their belief in their ability to continue strength training twice per week at the prescribed intensity in the future. Scores range from 0 to 100 and higher scores indicate greater self-efficacy.

  10. Exercise session attendance

    Time frame: From enrollment to the end of 20-week intervention period

    The total number of supervised exercise sessions attended by participants over the 20-week intervention period.

Study contacts

Contact information is provided by the study sponsor or research team.

Anoop T Balachandran, PhD

CONTACT

[email protected]

718-997-2729

Sponsors and collaborators

Lead sponsor

Queens College, The City University of New York

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Acronym: LOAD

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Feb 6, 2025
Registry last updated
Jul 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.